Paris Saclay Cancer Cluster (PSCC), shared on LinkedIn:
“Meet the winners of last year’s Hack4Hope challenge!
Aleck Jones, is the CEO and co-founder of Kindling Bio, a biotech developing targeted cancer gene therapy to harness the power of children’s immune system to fight a wide range of tumours.
Last year, Kindling Bio won the Hack4Hope first place:
‘Thanks to the Hack4Hope, Kindling Bio gained financial support, which has been really beneficial to drive our research and development program forward to get where we need to be to keep moving.’
His journey is a powerful example of how Hack4Hope transforms innovative ideas into concrete solutions for pediatric cancer.
This year, it’s your turn!
Join us for the 3rd edition of Hack4Hope on December 2, 2026, at the PSCC premises, in Villejuif!
This event is a unique opportunity for you meet researchers, clinicians, AI experts, other startups, and patients, to co-create tomorrow’s solutions for children and teenagers with cancers.
Apply now as a project before October 2:
Don’t miss this chance to accelerate your innovation and make a difference for children with cancer.”
Other articles about Hack4Hope on OncoDaily.